Ngozi Erondu
发表论文 70 篇 · 总被引 14452 次 · h-index 33
代表论文
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes (2017 · New England Journal of Medicine · 被引 7851)
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis (2015 · New England Journal of Medicine · 被引 815)
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials (2018 · The Lancet Diabetes & Endocrinology · 被引 647)
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events (2017 · Circulation · 被引 507)
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis (2014 · New England Journal of Medicine · 被引 393)
- Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program (2015 · Diabetes Care · 被引 325)